Skip to content

A before-after comparison study of a novel self-care application to develop an individualized lifestyle intervention to prevent and manage menopausal symptoms

A beore-after study on the effectiveness of the self-care application "HerLife" for menopausal symptoms - HerLife berfore-after study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052302
Enrollment
120
Registered
2023-09-25
Start date
2023-09-22
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menopausal symptoms

Interventions

The subjects will download the &quot
Her Life&quot
smartphone app (YStory Inc. / Japan) on their own iPhone and use it for 6 months (26 weeks). They will enter their symptoms into the app daily, and the researchers will look at the subject&#39
s symptom tracking data and measurement data for the past month and pick up the next month&#39
s health care plan from existing algorithms. The each subject will work on improving her lifestyle based on the health care plans and enter the actual actions she has taken into the app, reading colu

Sponsors

Kyoto University
Lead Sponsor
YStory Inc.
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Japanese women with irregular or absent menstrual cycles and menopausal symptoms Employed (full-time, temporary, or part-time, 3 or more days per week) The simplified menopausal index (SMI) score is between 25 and 66 points. Own an iPhone (iOS 16 or later) and can use mobile communication daily. Able to communicate and use apps in Japanese without any problems.

Exclusion criteria

Exclusion criteria: Those with the following comorbidities: coronary artery disease, pheochromocytoma, neurasthenia, psychiatric disorders, uncontrolled thyroid dysfunction, uncontrolled hypertension or any other comorbidity that the doctor considers unsuitable for study participation Those who have started using new drugs (e.g. hormone replacement therapy or antidepressants) within 30 days Those who are pregnant or lactating

Design outcomes

Primary

MeasureTime frame
Severity of menopausal symptoms: Modified version of the menopausal symptoms rating chart for Japanese women (26 weeks after the start of the intervention)

Countries

Japan

Contacts

Public ContactOhsuga Takuma

Kyoto University Graduate School of Medicine Department of Gynecology and Obstetrics

ohsuga@kuhp.kyoto-u.ac.jp075-751-3269

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026